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Organophosphorus agents (OPs) are irreversible inhibitors of acetylcholinesterase (AChE). OP
poisoning causes major cholinergic syndrome. Current medical counter-measures mitigate the
acute effects but have limited action against OP-induced brain damage. Bioscavengers are
appealing alternative therapeutic approach because they neutralize OPs in bloodstream before
they  reach  physiological  targets.  First  generation  bioscavengers  are  stoichiometric
bioscavengers. However, stoichiometric neutralization requires administration of huge doses of
enzyme. Second generation bioscavengers are catalytic bioscavengers capable of detoxifying
OPs with a turnover. High bimolecular rate constants (kcat/Km> 106M-1min-1) are required, so
that low enzyme doses can be administered. Cholinesterases (ChE) are attractive candidates
because OPs are hemi-substrates. Moderate OP hydrolase (OPase) activity has been observed
for certain natural ChEs and for G117H-based human BChE mutants made by site-directed
mutagenesis. However, before mutated ChEs can become operational catalytic bioscavengers
their dephosphylation rate constant must be increased by several orders of magnitude. New
strategies for converting ChEs into fast OPase are based either on combinational approaches or
on computer redesign of enzyme. The keystone for rational conversion of ChEs into OPases is to
understand the reaction mechanisms with OPs. In the present work we propose that efficient OP
hydrolysis can be achieved by re-designing the configuration of enzyme active center residues
and by creating specific routes for attack of water molecules and proton transfer. Four directions
for nucleophilic attack of water on phosphorus atom were defined. Changes must lead to a novel
enzyme, wherein OP hydrolysis wins over competing aging reactions. Kinetic, crystallographic,
and  computational  data  have  been  accumulated  that  describe  mechanisms  of  reactions
involving ChEs. From these studies, it appears that introducing new groups that create a stable
H-bonded network susceptible to activate and orient water molecule, stabilize transition states
(TS),  and  intermediates  may  determine  whether  dephosphylation  is  favored  over  aging.
Mutations on key residues (L286, F329, F398) were considered. QM/MM calculations suggest
that mutation L286H combined to other mutations favors water attack from apical position.
However, the aging reaction is competing. Axial direction of water attack is not favorable to
aging. QM/MM calculation shows that F329H+F398H-based multiple mutants display favorable
energy barrier for fast reactivation without aging.
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